IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,969,645 | +103.0% | 155,500 | +0.3% | 0.13% | +150.9% |
| Q2 2023 | $2,940,350 | -64.1% | 155,000 | -70.6% | 0.05% | -57.6% |
| Q1 2023 | $8,189,280 | -12.6% | 528,000 | 0.0% | 0.12% | +8.7% |
| Q4 2022 | $9,372,000 | +388.1% | 528,000 | +51.5% | 0.12% | +447.6% |
| Q1 2022 | $1,920,000 | -35.3% | 348,400 | 0.0% | 0.02% | -34.4% |
| Q4 2021 | $2,968,000 | +208.2% | 348,400 | +214.4% | 0.03% | +220.0% |
| Q3 2021 | $963,000 | – | 110,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |